PubRank

S Lancrenon

Author PubWeight™ 35.22‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Systematic clinical methodology for validating bipolar-II disorder: data in mid-stream from a French national multi-site study (EPIDEP). J Affect Disord 1998 1.66
2 The treatment of negative symptoms and deficit states of chronic schizophrenia: olanzapine compared to amisulpride and placebo in a 6-month double-blind controlled clinical trial. Acta Psychiatr Scand 2006 1.50
3 [New medical device hospital assessment: what kind of clinical data?]. Ann Pharm Fr 2012 1.38
4 Cyclothymic temperament as a prospective predictor of bipolarity and suicidality in children and adolescents with major depressive disorder. J Affect Disord 2005 1.22
5 [Modern typology of symptoms and obsessive-compulsive syndromes: results of a large French study of 615 patients]. Encephale 1996 1.04
6 Three-dimensional structure of the Hospital Anxiety and Depression Scale in a large French primary care population suffering from major depression. Psychiatry Res 2001 1.02
7 Toward a refined phenomenology of mania: combining clinician-assessment and self-report in the French EPIMAN study. J Affect Disord 2001 1.02
8 Gender, temperament, and the clinical picture in dysphoric mixed mania: findings from a French national study (EPIMAN). J Affect Disord 1998 1.02
9 Suicidal behaviour in a French Cohort of major depressive patients: characteristics of attempters and nonattempters. J Affect Disord 2009 0.98
10 Clinical and psychometric characterization of depression in mixed mania: a report from the French National Cohort of 1090 manic patients. J Affect Disord 2006 0.97
11 Cyclothymic OCD: a distinct form? J Affect Disord 2003 0.94
12 Validating affective temperaments in their subaffective and socially positive attributes: psychometric, clinical and familial data from a French national study. J Affect Disord 2005 0.94
13 Breast-conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French Survey experience. Br J Cancer 2009 0.93
14 [Frequency and clinical aspects of bipolar II disorder in a French multicenter study: EPIDEP]. Encephale 2001 0.88
15 [Bipolar obsessive-compulsive disorder: confirmation of results of the "ABC-OCD" survey in 2 populations of patient members versus non-members of an association]. Encephale 2002 0.88
16 Catecholamines metabolism in infantile autism: a controlled study of 22 autistic children. J Autism Dev Disord 1987 0.86
17 The feasibility of self-assessment of dysphoric mania in the French national EPIMAN study. J Affect Disord 2001 0.86
18 [Comparative double-blind study of bromazepam versus prazepam in non-psychotic anxiety]. Encephale 1994 0.86
19 [Herpetic stomatitis-gingivitis in children: controlled trial of acyclovir versus placebo]. Ann Pediatr (Paris) 1988 0.85
20 Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study. J Affect Disord 2005 0.84
21 Salt or no salt in the treatment of cirrhotic ascites: a randomised study. Gut 1986 0.84
22 [The Pleasure-Displeasure Scale. Use in the evaluation of depressive illness]. Encephale 1987 0.81
23 [Retardation in depressive states : elaboration of a quantitative rating scale (author's transl)]. Encephale 1980 0.79
24 Validating the soft bipolar spectrum in the French National EPIDEP Study: the prominence of BP-II 1/2. J Affect Disord 2006 0.79
25 [Prevalence of obsessive-compulsive disorders in a large French patient population in psychiatric consultation]. Encephale 1996 0.78
26 [Factor structure of the H.S.C.L. in a sample of French anxious-depressed patients]. Ann Med Psychol (Paris) 1984 0.78
27 Baseline and prodromal characteristics of first- versus multiple-episode mania in a French cohort of bipolar patients. Eur Psychiatry 2011 0.78
28 Religious involvement in major depression: protective or risky behavior? The relevance of bipolar spectrum. J Affect Disord 2013 0.77
29 [Pain in the elderly. A study of 183 consecutive subjects hospitalized in a geriatric medical ward]. Presse Med 1999 0.77
30 "Folie circulaire" vs "Folie à double forme": contribution from a French national study. Eur Psychiatry 2010 0.77
31 Rating scale for the assessment of communication disorders in schizophrenics. Eur Psychiatry 1997 0.77
32 [Ductal carcinoma in situ of the breast (DCIS). Histopathological features and treatment modalities: analysis of 1,289 cases]. Bull Cancer 2010 0.77
33 [Repeat evaluation of impulsiveness in a cohort of 155 patients with obsessive-compulsive disorder: 12 months prospective follow-up]. Encephale 1997 0.76
34 [Prospective follow-up over a 12 month period of a cohort of 155 patients with obsessive-compulsive disorder: phase III National DRT-TOC Study]. Encephale 2001 0.76
35 Psychopharmacological profile of the new cognition enhancing agent exifone in the mouse. Arzneimittelforschung 1987 0.76
36 [Validation of M. Weissman's social adaptation questionnaire in its French version]. Ann Med Psychol (Paris) 1995 0.76
37 [The study of the efficacy of fluoxetine versus tianeptine in the treatment of elderly depressed patients followed in general practice]. Encephale 1999 0.76
38 [Metabolism of serotonin in autism in children]. Encephale 1989 0.76
39 Determination of the optimal dosage regimen of captopril + hydrochlorothiazide in the treatment of moderate arterial hypertension. Br J Clin Pharmacol 1987 0.75
40 [Clinical aspects of obsessive-compulsive syndromes: results of phase 2 of a large French survey]. Encephale 1997 0.75
41 [Postoperative haemodynamic evaluation of myocardial protection by physicochemical cardioplegia. Hyperkaliemic, hyperosmolar and acid solution at 4 degrees C (author's transl)]. Nouv Presse Med 1979 0.75
42 [A controlled double-blind study of tetrabamate versus lorazepam and placebo in generalized anxiety]. Encephale 1992 0.75
43 [Disorders of catecholamine metabolism in infantile autism. Comparative study of 22 autistic children]. Encephale 1989 0.75
44 Time-stability of the "Functional Remission of General Schizophrenia" (FROGS) scale. Eur Psychiatry 2011 0.75
45 [Widlöcher's depression scale. Examination of a sample of nondepressed, nondejected subjects. II]. Ann Med Psychol (Paris) 1983 0.75
46 [Existence of asymptomatic changes in left ventricular function in the diabetic. Noninvasive study]. Rev Med Interne 1985 0.75
47 [Fibrinogen and pentoxifylline. Results of a French cooperative exploratory study of stage II arteritis]. J Mal Vasc 1989 0.75
48 [Erection disorders: efficacy and tolerability after 6 months of intracavernous self-injections of alprostadil. Groupe Français d'Etude de l'Alprostadil]. Presse Med 1994 0.75
49 Is psychosis in DSM-IV mania due to severity? The relevance of selected demographic and comorbid social-phobic features. Acta Psychiatr Scand 2007 0.75
50 [Evaluation of functional remission in schizophrenic disorder. The FROGS Scale]. Encephale 2013 0.75
51 [Clonidine versus a placebo trial in manic disorder]. Encephale 1990 0.75
52 Factors associated with borderline personality disorder in major depressive patients and their relationship to bipolarity. Eur Psychiatry 2013 0.75
53 [Why a new population, why a new scale. Definition and measurement of a new syndrome: neurobiological deficit in individuals over 50 years of age]. Rev Prat 1988 0.75
54 Diflunisal versus placebo for treatment of pain in general practice. Clin Ther 1982 0.75
55 [Effect of antidepressant treatment on sense of dyscontrol: preliminary studies]. Encephale 1995 0.75
56 Fibrinogen and pentoxifylline. Thromb Res 1989 0.75
57 [Distinction between anxiety state/trait in general practice: a descriptive study]. Encephale 1999 0.75
58 [Double-blind study of the efficacy of an antiserotoninergic drug, pizotifen, in Duchenne's muscular dystrophy]. Arch Fr Pediatr 1987 0.75
59 [Major agitated-anxious versus blunted-retarded depression: differential effects of fluoxetine]. Encephale 1995 0.75
60 Depression and associated organic diseases: are there any specific depressive symptoms? Results from the dialogue-2 survey. Eur Psychiatry 2004 0.75